22-39045501-C-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145298.6(APOBEC3F):c.525C>A(p.Asp175Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000632 in 1,614,166 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145298.6 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
APOBEC3F | NM_145298.6 | c.525C>A | p.Asp175Glu | missense_variant | 4/7 | ENST00000308521.10 | NP_660341.2 | |
APOBEC3F | XM_047441184.1 | c.732C>A | p.Asp244Glu | missense_variant | 3/6 | XP_047297140.1 | ||
APOBEC3F | XM_047441185.1 | c.525C>A | p.Asp175Glu | missense_variant | 4/5 | XP_047297141.1 | ||
APOBEC3F | XM_017028642.3 | c.525C>A | p.Asp175Glu | missense_variant | 4/5 | XP_016884131.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000723 AC: 11AN: 152178Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000107 AC: 27AN: 251466Hom.: 0 AF XY: 0.000110 AC XY: 15AN XY: 135908
GnomAD4 exome AF: 0.0000622 AC: 91AN: 1461870Hom.: 0 Cov.: 34 AF XY: 0.0000550 AC XY: 40AN XY: 727244
GnomAD4 genome AF: 0.0000722 AC: 11AN: 152296Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74452
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 25, 2022 | The c.525C>A (p.D175E) alteration is located in exon 4 (coding exon 4) of the APOBEC3F gene. This alteration results from a C to A substitution at nucleotide position 525, causing the aspartic acid (D) at amino acid position 175 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at